Most cited papers from MS4 Research Institute

MS4 Research Institute

What are the most cited papers from MS4 Research Institute?

The most cited paper from MS4 Research Institute is "Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Imaging" (Marianne A.A. van Walderveen, Geert J. Lycklama à Nijeholt, Herman J. Adèr et al., 2001), with 137 citations. Next come "Ambulatory Monitoring of Activities and Motor Symptoms in Parkinson's Disease" (134) and "Contractile properties and fatigue of quadriceps muscles in multiple sclerosis" (132).

Published TypeFieldAccessCitations

Showing 50 of 70 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Imaging Marianne A.A. van Walderveen, Geert J. Lycklama à Nijeholt, Herman J. Adèr et al. · Archives of Neurology	2001	137
2	Ambulatory Monitoring of Activities and Motor Symptoms in Parkinson's Disease Daphne G.M. Zwartjes, Tjitske Heida, Jeroen P.P. van Vugt et al. · IEEE Transactions on Biomedical Engineering	21 May 2010	134
3	Contractile properties and fatigue of quadriceps muscles in multiple sclerosis ARNOLD DE HAAN, Cornelis J. de Ruiter, Lucas H. V. van der Woude et al. · Muscle & Nerve	2000	132
4	Cognitive Impairment in Multiple Sclerosis Jill S. Fischer Book chapter	30 Mar 2001	103
5	Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system Peter Joseph Jongen, W.H. Doesburg, J. L. M. Ibrahim-Stappers et al. · Acta Neurologica Scandinavica	Feb 2000	87
6	Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial Mads Henrik Ravnborg, Per Soelberg Sørensen, Magnus Andersson et al. · The Lancet Neurology	10 Jun 2010	76
7	The role of helplessness as mediator between neurological disability, emotional instability, experienced fatigue and depression in patients with multiple sclerosis Sieberen P. van der Werf, Andrea W.M. Evers, Peter Joseph Jongen et al. · Multiple Sclerosis Journal	Feb 2003	69
8	Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis H.-F. Petereit, Ralf Pukrop, Franz Fazekas et al. · Journal of the Neurological Sciences	30 Jan 2003	56
9	Relationship between Working Hours and Power of Attention, Memory, Fatigue, Depression and Self-Efficacy One Year after Diagnosis of Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis Peter Joseph Jongen, Keith Andrew Wesnes, Björn van Geel et al. · PLoS ONE Open access	May 2014	53
10	European Study on Intravenous Immunoglobulin in Multiple Sclerosis Massimo Filippi, Maria Assunta Rocca, Elisabetta Pagani et al. · Archives of Neurology	Sep 2004	53
11	Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study Peter Joseph Jongen, Dirk Lehnick, Evert A. C. M. Sanders et al. · Health and Quality of Life Outcomes Open access	2010	50
12	Psychiatric onset of multiple sclerosis Peter Joseph Jongen · Journal of the Neurological Sciences	27 Apr 2006	49
13	Symbol Digit Modalities Test Variant in a Smartphone App for Persons With Multiple Sclerosis: Validation Study Pim van Oirschot, Marco A. P. Heerings, Karine Wendrich et al. · JMIR mhealth and uhealth Open access	5 Oct 2020	46
14	Cognitive performance in relapsing remitting multiple sclerosis: A longitudinal study in daily practice using a brief computerized cognitive battery Chris J. Edgar, Peter Joseph Jongen, Evert A. C. M. Sanders et al. · BMC Neurology Open access	7 Jun 2011	39
15	Association between MRI parameters and the MS severity scale: a 12 year follow-up study Arjan Minneboo, BMJ Uitdehaag, P.J.H. Jongen et al. · Multiple Sclerosis Journal	23 Apr 2009	39
16	Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study Peter Joseph Jongen, Rob P. Ruimschotel, Marco A. P. Heerings et al. · Health and Quality of Life Outcomes Open access	2014	38
17	The FAS−670 polymorphism influences susceptibility to multiple sclerosis Tineke van Veen, Nynke F. Kalkers, J. Bart A. Crusius et al. · Journal of Neuroimmunology	Jul 2002	37
18	Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling Ingrid Kremer, Silvia Evers, Peter Joseph Jongen et al. · PLoS ONE Open access	3 Nov 2016	36
19	Contractile speed and fatigue of adductor pollicis muscle in multiple sclerosis Cornelis J. de Ruiter, Peter Joseph Jongen, Lucas H. V. van der Woude et al. · Muscle & Nerve Open access	2 Aug 2001	33
20	Neuromyelitis optica with clinical and histopathological involvement of the brain Gerald J. D. Hengstman, Pieter Wesseling, Cor W.G.M. Frenken et al. · Multiple Sclerosis Journal	9 Feb 2007	32
21	Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a The Functional composite and quality of Life in Avonex-treated Relapsing multipl, Peter Joseph Jongen, Christian Sindic et al. · Journal of Neurology	17 Nov 2009	32
22	Sexual dysfunction in men with multiple sclerosis — A comprehensive pilot-study into etiology PEM Lottman, PJH Jongen, PFWM Rosier et al. · International Journal of Impotence Research	Dec 1998	28
23	Adherence to dietary guidelines is associated with better physical and mental quality of life: results from a cross-sectional survey among 728 Dutch MS patients Ilse Evers, Marco A. P. Heerings, Nicole M. de Roos et al. · Nutritional Neuroscience Open access	12 Feb 2021	27
24	Comparison of preferences of healthcare professionals and MS patients for attributes of disease‐modifying drugs: A best‐worst scaling Ingrid Kremer, Silvia Evers, Peter Joseph Jongen et al. · Health Expectations Open access	21 Jul 2017	27
25	Sperm-Associated Antigen 16 Is a Novel Target of the Humoral Autoimmune Response in Multiple Sclerosis Laura Bock, Klaartje Somers, Judith Fraussen et al. · The Journal of Immunology Open access	2 Aug 2014	26
26	Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis Marcel M. Verbeek, E. A. Notting, Brigitte H. W. Faas et al. · Acta Neurologica Scandinavica	20 Nov 2009	26
27	Cerebrospinal Fluid IgM Index Correlates with Cranial MRI Lesion Load in Patients with Multiple Sclerosis Peter Joseph Jongen, Geert J. Lycklama à Nijeholt, Karel J.B Lamers et al. · European Neurology	2007	26
28	Anaphylactoid reaction to intravenous methylprednisolone in a patient with multiple sclerosis Jan S.P. van den Berg, Otto R. Hommes, E.W. Wuis et al. · Journal of Neurology Neurosurgery & Psychiatry Open access	Dec 1997	22
29	Multiple sclerosis patients with bladder dysfunction have decreased symptoms after electro-acupuncture SH Tjon Eng Soe, Kopsky Dj, PJH Jongen et al. · Multiple Sclerosis Journal	Nov 2009	22
30	Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis? Peter Joseph Jongen, Keith Andrew Wesnes, Björn van Geel et al. · Multiple Sclerosis International Open access	2015	20
31	High-performance liquid chromatography analysis, preliminary pharmacokinetics, metabolism and renal excretion of methylprednisolone with its C6 and C20 hydroxy metabolites in multiple sclerosis patients receiving high-dose pulse therapy Tom B. Vree, Aart J. Lagerwerf, C.P.W.G.M. Verwey-van Wissen et al. · Journal of Chromatography B Biomedical Sciences and Applications	Sep 1999	20
32	Caregiver strain among life partners of persons with mild disability due to relapsing-remitting multiple sclerosis Karin van der Hiele, Dennis A. M. van Gorp, Marco A. P. Heerings et al. · Multiple Sclerosis and Related Disorders Open access	6 Mar 2019	19
33	Risk knowledge of people with relapsing-remitting multiple sclerosis – Results of an international survey Andrea Giordano, Katrin Liethmann, Sascha Köpke et al. · PLoS ONE Open access	29 Nov 2018	19
34	Improved health-related quality of life, participation, and autonomy in patients with treatment-resistant chronic pain after an intensive social cognitive intervention with the participation of support partners Peter Joseph Jongen, Rob P. Ruimschotel, Yvonne Museler-Kreijns et al. · Journal of Pain Research Open access	30 Nov 2017	19
35	Identification of coronin‐1a as a novel antibody target for clinically isolated syndrome and multiple sclerosis Myrthe Rouwette, Jean‐Paul Noben, Jack van Horssen et al. · Journal of Neurochemistry Open access	10 Jun 2013	19
36	The Interactive Web-Based Program MSmonitor for Self-Management and Multidisciplinary Care in Persons With Multiple Sclerosis: Quasi-Experimental Study of Short-Term Effects on Patient Empowerment Peter Joseph Jongen, Gezien ter Veen, Wim A.J.G. Lemmens et al. · Journal of Medical Internet Research Open access	9 Mar 2020	18
37	Empathy in multiple sclerosis––Correlates with cognitive, psychological and occupational functioning Karin van der Hiele, Elianne E. A. van Egmond, Peter Joseph Jongen et al. · Multiple Sclerosis and Related Disorders Open access	2 Mar 2020	17
38	Adverse Events of Interferon Beta-1a: A Prospective Multi-Centre International ICH-GCP-Based CRO-Supported External Validation Study in Daily Practice Peter Joseph Jongen, Christian Sindic, Evert A. C. M. Sanders et al. · PLoS ONE Open access	25 Oct 2011	16
39	A Two-Minute Walking Test With a Smartphone App for Persons With Multiple Sclerosis: Validation Study Pim van Oirschot, Marco A. P. Heerings, Karine Wendrich et al. · JMIR Formative Research Open access	17 Nov 2021	15
40	Work difficulties in people with multiple sclerosis: The role of anxiety, depression and coping Elianne E. A. van Egmond, Karin van der Hiele, DAM van Gorp et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical Open access	Jul 2022	14
41	Effect of an intensive 3-day social cognitive treatment (can do treatment) on control self-efficacy in patients with relapsing remitting multiple sclerosis and low disability: A single-centre randomized controlled trial Peter Joseph Jongen, Ghislaine A. P. G. van Mastrigt, Marco A. P. Heerings et al. · PLoS ONE Open access	10 Oct 2019	14
42	Drug adherence and multidisciplinary care in patients with multiple sclerosis: Protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study) Peter Joseph Jongen, Gerald J. D. Hengstman, Raymond Hupperts et al. · BMC Neurology Open access	30 Mar 2011	14
43	High-performance Liquid-chromatographic-Atmospheric-pressure Chemical-ionization Ion-trap Mass-spectrometric Identification of Isomeric C6-hydroxy and C20-hydroxy Metabolites of Methylprednisolone in the Urine of Patients Receiving High-dose Pulse Therapy Tom B. Vree, Louis Maljers, Noud Van Den Borg et al. · Journal of Pharmacy and Pharmacology	Oct 1999	14
44	Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development Ingrid Kremer, Peter Joseph Jongen, Silvia Evers et al. · BMC Medical Informatics and Decision Making Open access	9 Apr 2021	13
45	Self-reported occupational functioning in persons with relapsing-remitting multiple sclerosis: Does personality matter? Karin van der Hiele, Dennis A. M. van Gorp, Elianne E. A. van Egmond et al. · Journal of the Neurological Sciences Open access	29 Jun 2021	12
46	A Dutch validation study of the Multiple Sclerosis Work Difficulties Questionnaire in relapsing remitting multiple sclerosis Elianne E. A. van Egmond, Dennis A. M. van Gorp, Cynthia A. Honan et al. · Disability and Rehabilitation Open access	8 Nov 2019	12
47	Composite cerebrospinal fluid score in relapsing-remitting and secondary progressive multiple sclerosis P JH Jongen, Sarah Floris, W.H. Doesburg et al. · Multiple Sclerosis Journal	Jun 1998	12
48	Isolation and identification of the C6-hydroxy and C20-hydroxy metabolites and glucuronide conjugate of methylprednisolone by preparative high-performance liquid chromatography from urine of patients receiving high-dose pulse therapy Tom B. Vree, C.P.W.G.M. Verwey-van Wissen, Aart J. Lagerwerf et al. · Journal of Chromatography B Biomedical Sciences and Applications	Apr 1999	12
49	A prospective web-based patient-centred interactive study of long-term disabilities, disabilities perception and health-related quality of life in patients with multiple sclerosis in The Netherlands: the Dutch Multiple Sclerosis Study protocol Peter Joseph Jongen, Marco A. P. Heerings, Wim A.J.G. Lemmens et al. · BMC Neurology Open access	3 Aug 2015	12
50	Subjective cognitive impairment is related to work status in people with multiple sclerosis Jade van Wegen, Elianne E. A. van Egmond, RHB Benedict et al. · IBRO Neuroscience Reports Open access	2 Nov 2022	11

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.